Quarterly Updates6 Oct 2025, 04:13 pm
Metropolis Healthcare Ltd. Reports 23% Y-o-Y Revenue Growth in Q2FY26
AI Summary
Metropolis Healthcare Ltd. has reported a 23% year-on-year revenue growth at the consolidated level for Q2FY26. The growth was driven by robust momentum in preventive health check-ups like TruHealth and wellness offerings. The company's performance was resilient despite lower incidence of seasonal illnesses. Key highlights include strong EBITDA margins, margin expansion at Core Diagnostics, and growth in TruHealth and Specialty segments.
Key Highlights
- Revenue growth of approx. 23% on a Y-o-Y basis
- Core Diagnostics operating at a high single-digit margin in Q2FY26
- TruHealth Wellness and Specialty segments recorded Y-o-Y growth of ~25% and ~36%, respectively
- B2C revenues registered a Y-o-Y growth of around 16% and B2B revenue growth stood at ~34%
- Company is debt free and has a net cash surplus of ~INR 55 crores